Sentence examples for pharmaceutical detailing from inspiring English sources

Pharmaceutical "detailing" is the term used to describe those sales visits in which drug reps go to doctors' offices to describe the benefits of a specific drug.

The medical culture surrounding antimicrobial drug prescribing in the United States is influenced by multiple external factors (e.g., peer practices, pharmaceutical detailing, geographic region, and managed care restrictions), and these may influence practice more than knowledge of current guidelines.

The relatively high proportion of prescriptions written using the brand name could possibly indicate the effect of pharmaceutical detailing and marketing efforts and routine prescribing of branded drugs by the GPs [ 24].

Other mechanisms for supporting providers in the retail setting, such as pharmaceutical "detailing" or short-course format training, may be more feasible and could possibly play an important role in strengthening access to ECP.

The sections on "Action and Uses" in this supplement will interest many who are not concerned with pharmaceutical details.

For example, a pharmaceutical detail person calling on physicians has a very different job from an account executive selling apparel or an account manager selling materials-handling systems.

The list of pharmaceutical products detailed above reflects the 'golden age' of the blockbuster; the industry is no longer able to deliver products that hold this level of commercial potential to the market with nearly as much regularity.

This practice is known within the pharmaceutical industry as "detailing".

Opinion-leader activity is also stepped up when there are shifts in market dynamics, says Nair. "The launch of a new competitive drug, the withdrawal of a drug from market, or the issuance of new guidelines by the Department of Health and Human Services and/or the National Institutes of Health each make pharmaceutical firms intensify their detailing efforts to opinion leaders," he says.

Formal training of private providers is probably needed, rather than depending solely on drug detailing by pharmaceutical company representatives.

As mentioned above, an alternative approach besides drug detailing by pharmaceutical companies, that have profits in mind and may not want to discuss the potential harm of antibiotics, will be needed to address the issue of antibiotics.